1[1]Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force [J]. Biochim et Biophys Acta, 1992, 1104 (1): 226
3[3]Cevc G, Schatzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements [J]. Biochimica et Biophysica Acta, 2002, 1564 (1): 21
4[4]El Maghraby GM, Williams AC, Barry BW. Skin delivery of estradiol from lipid vesicles: importance of liposome structure [J]. International Journal of Pharmaceutics, 2000, 204 (1～2): 159
5[5]Hadgraft J. Modulation of the barrier function of the skin [J]. Skin Pharmacology ＆ Applied Skin Physiology, 2001, 14(1): 72
7[7]El Maghraby GM, Williams AC, Barry BW. Skin delivery of estradiol from deformable and traditional liposomes: mechanistic studies [J]. Journal of Pharmacy ＆ Pharmacology,1999, 51 (10): 1123
8[8]El Maghraby GM, Williams AC, Barry BW. Estradiol skin delivery of from ultradeformable liposomes: refinement of surfactant concentration [J]. International Journal of Pharmaceutics, 2000, 196 (1): 63
9[9]El Maghraby GM, Williams AC, Barry BW. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro [J]. Journal of Pharmacy ＆ Pharmacology, 2001, 53(8): 1069
10[10]El Maghraby GM, Williams AC, Barry BW. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes [J]. J PharmPharmacol, inPress, 2001, 53 (10): 1311
2[2]Rathbone MJ, Ponchel G, Ghazalil A. Oral Mucosal Drug Delivery [M]. New York: Marcel Dekker, 1996.242-253.
3[3]Farshi FS, Ozen AY, Ercan MT, et al. In vivo studies in the treatment of oral ulcers with liposomal dexamethasone phosphate [J]. J Microencapsul, 1996,13(3):537-544.
4[4]Betageri GV, Jenkins SA, Parsons DL. Liposome Drug Delivery Systems [M]. Lancaster/Basel: Technomic, 1993.65-88.
5[5]Al-Achi A, Greenwoood R. Buccal administration of human insulin in streptozocin-diabetic rats [J]. Res Commun Chem Pathol Pharmacol, 1993,82(4):297-306.
6[6]Cevc G, Blume G, Schzlein A, et al. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers [J]. Adv Drug Deliv Rev, 1996,18(2):349-378.
7[7]Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes[J]. Biomaterials, 2000,21(3):1879-1885.
8[8]Gamal MM, Maghraby E, Adrian C, et al. Oestradiol skin delivery from ultradeformable liposome: refinement of surfactant concentration [J]. Int J Pharm, 2000,196(5):63-74.
9[9]Nagai T, Machida Y. Buccal delivery systems using hydrogels [J]. Adv Drug Deliv Rev, 1993,11(3):179-191.
10[10]Aungst BJ, Rogers NJ. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery [J]. Int J Pharm, 1989,53(2):227-235.
